{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:52:11Z","timestamp":1792403531379,"version":"4.4.0"},"reference-count":215,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.pharmthera.2022.108186","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T10:49:11Z","timestamp":1649501351000},"page":"108186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["The role of hypoxia-inducible factors in cardiovascular diseases"],"prefix":"10.1016","volume":"238","author":[{"given":"Baoqi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guomin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2022.108186_bb0005","doi-asserted-by":"crossref","first-page":"884","DOI":"10.5551\/jat.RV17009","article-title":"The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases","volume":"24","author":"Abe","year":"2017","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0010","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1073\/pnas.1120385109","article-title":"Digoxin inhibits development of hypoxic pulmonary hypertension in mice","volume":"109","author":"Abud","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0015","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/HYPERTENSIONAHA.115.05886","article-title":"Endothelial hypoxia-inducible factor-1alpha promotes atherosclerosis and monocyte recruitment by upregulating MicroRNA-19a","volume":"66","author":"Akhtar","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0020","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/1074248414524480","article-title":"Investigating mitochondrial metabolism in contracting HL-1 cardiomyocytes following hypoxia and pharmacological HIF activation identifies HIF-dependent and independent mechanisms of regulation","volume":"19","author":"Ambrose","year":"2014","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0025","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/01.CIR.28.5.915","article-title":"The terminal portion of the pulmonary arterial tree in people native to high altitudes","volume":"28","author":"Arias-Stella","year":"1963","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.201302-0302OC","article-title":"Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1alpha","volume":"189","author":"Ball","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bib1040","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/ATVBAHA.119.312509","article-title":"Hypoxia Triggers Osteochondrogenic Differentiation of Vascular Smooth Muscle Cells in an HIF-1 (Hypoxia-Inducible Factor 1)-Dependent and Reactive Oxygen Species-Dependent Manner","volume":"39","author":"Balogh","year":"2019","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/FJC.0b013e3181e2bfef","article-title":"Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat","volume":"56","author":"Bao","year":"2010","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0040","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1096\/fj.201600557R","article-title":"Loss of smooth muscle cell hypoxia inducible factor-1alpha underlies increased vascular contractility in pulmonary hypertension","volume":"31","author":"Barnes","year":"2017","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0271678X15624933","article-title":"Neuronal HIF-1alpha and HIF-2alpha deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke","volume":"37","author":"Barteczek","year":"2017","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0050","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1113\/EP086051","article-title":"Impact of obstructive sleep apnoea and intermittent hypoxia on cardiovascular and cerebrovascular regulation","volume":"102","author":"Beaudin","year":"2017","journal-title":"Experimental Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011693","article-title":"Conditional HIF-1alpha expression produces a reversible cardiomyopathy","volume":"5","author":"Bekeredjian","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0060","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002407R","article-title":"Hypoxia-inducible factor-dependent induction of myeloid-derived netrin-1 attenuates natural killer cell infiltration during endotoxin-induced lung injury","volume":"35","author":"Berg","year":"2021","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","article-title":"Metabolic remodelling in heart failure","volume":"15","author":"Bertero","year":"2018","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fcvm.2018.00124","article-title":"Medial hypoxia and adventitial vasa vasorum remodeling in human ascending aortic aneurysm","volume":"5","author":"Billaud","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0075","doi-asserted-by":"crossref","first-page":"13414","DOI":"10.1073\/pnas.1903510116","article-title":"HIF-1alpha is required for development of the sympathetic nervous system","volume":"116","author":"Bohuslavova","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0080","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1161\/CIRCRESAHA.107.153346","article-title":"Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia","volume":"101","author":"Bosch-Marce","year":"2007","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0085","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI15496","article-title":"Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia","volume":"111","author":"Brusselmans","year":"2003","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","article-title":"Mechanisms of angiogenesis and arteriogenesis","volume":"6","author":"Carmeliet","year":"2000","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0095","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0100","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nm1075","article-title":"Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1","volume":"10","author":"Ceradini","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12933-018-0713-0","article-title":"Adverse effects of Hif1a mutation and maternal diabetes on the offspring heart","volume":"17","author":"Cerychova","year":"2018","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0110","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1161\/ATVBAHA.115.306171","article-title":"Deficiency of HIF1alpha in antigen-presenting cells aggravates atherosclerosis and type 1 T-helper cell responses in mice","volume":"35","author":"Chaudhari","year":"2015","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1196\/annals.1383.005","article-title":"Hypoxia at the site of abdominal aortic aneurysm rupture is not associated with increased lactate","volume":"1085","author":"Choke","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0120","doi-asserted-by":"crossref","DOI":"10.1177\/2048004020959574","article-title":"Netrin-1: Focus on its role in cardiovascular physiology and atherosclerosis","volume":"9","author":"Claro","year":"2020","journal-title":"JRSM Cardiovascular Disease"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0125","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cardiores.2003.07.003","article-title":"Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha","volume":"60","author":"Compernolle","year":"2003","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0130","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1073\/pnas.1602978113","article-title":"HIF2alpha-arginase axis is essential for the development of pulmonary hypertension","volume":"113","author":"Cowburn","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0135","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.28755","article-title":"Cardiovascular adaptation to hypoxia and the role of peripheral resistance","volume":"6","author":"Cowburn","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","article-title":"HIF-1alpha is essential for myeloid cell-mediated inflammation","volume":"112","author":"Cramer","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0145","doi-asserted-by":"crossref","DOI":"10.1242\/dev.157511","article-title":"Late neuroprogenitors contribute to normal retinal vascular development in a Hif2a-dependent manner","volume":"145","author":"Cristante","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.04.034","article-title":"Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36","volume":"229","author":"Crucet","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0155","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1161\/CIRCULATIONAHA.116.021494","article-title":"Prolyl-4 hydroxylase 2 (PHD2) deficiency in endothelial cells and hematopoietic cells Induces obliterative vascular remodeling and severe pulmonary arterial hypertension in mice and humans through hypoxia-inducible factor-2alpha","volume":"133","author":"Dai","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0160","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1164\/rccm.201710-2079OC","article-title":"Therapeutic targeting of vascular remodeling and right heart failure in pulmonary arterial hypertension with a HIF-2alpha inhibitor","volume":"198","author":"Dai","year":"2018","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0165","doi-asserted-by":"crossref","first-page":"C314","DOI":"10.1152\/ajpcell.00374.2004","article-title":"Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury","volume":"288","author":"Date","year":"2005","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0170","first-page":"3226","article-title":"Altered expressions of alkane monooxygenase and hypoxia inducible factor-1alpha expression in lung tissue of rat hypoxic pulmonary hypertension","volume":"93","author":"Deng","year":"2013","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0175","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrc2468","article-title":"Hypoxia, HIF1 and glucose metabolism in the solid tumour","volume":"8","author":"Denko","year":"2008","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.pharmthera.2022.108186_bib1034","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCRESAHA.109.208967","article-title":"Critical role for leukocyte hypoxia inducible factor-1alpha expression in post-myocardial infarction left ventricular remodeling","volume":"106","author":"Dong","year":"2010","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0180","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ymthe.2018.05.004","article-title":"Differential but complementary HIF1alpha and HIF2alpha transcriptional regulation","volume":"26","author":"Downes","year":"2018","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.6028\/jres.113.018","article-title":"Stiffening of the extrapulmonary arteries from rats in chronic hypoxic pulmonary hypertension","volume":"113","author":"Drexler","year":"2008","journal-title":"Journal of Research of the National Institute of Standards and Technology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.tvir.2016.04.001","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia","volume":"19","author":"Dua","year":"2016","journal-title":"Techniques in Vascular and Interventional Radiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0195","doi-asserted-by":"crossref","first-page":"C260","DOI":"10.1152\/ajpcell.00315.2015","article-title":"Hypoxia-inducible factor 3 biology: complexities and emerging themes","volume":"310","author":"Duan","year":"2016","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0200","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1542\/pir.20.11.e91","article-title":"Mechanisms of structural remodeling in chronic pulmonary hypertension","volume":"20","author":"Durmowicz","year":"1999","journal-title":"Pediatrics in Review"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0205","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCULATIONAHA.107.758516","article-title":"Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning","volume":"118","author":"Eckle","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0210","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.20050177","article-title":"HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia","volume":"202","author":"Eltzschig","year":"2005","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0215","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.molmed.2013.02.005","article-title":"Attenuating myocardial ischemia by targeting A2B adenosine receptors","volume":"19","author":"Eltzschig","year":"2013","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0220","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2004-06-2066","article-title":"Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism","volume":"104","author":"Eltzschig","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0225","first-page":"73","article-title":"Nucleotide metabolism and cell-cell interactions","volume":"341","author":"Eltzschig","year":"2006","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0230","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","article-title":"Endothelial dysfunction","volume":"15","author":"Endemann","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0235","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000318806","article-title":"Hypoxia in abdominal aortic aneurysm supports a role for HIF-1alpha and Ets-1 as drivers of matrix metalloproteinase upregulation in human aortic smooth muscle cells","volume":"48","author":"Erdozain","year":"2011","journal-title":"Journal of Vascular Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0240","first-page":"R160","article-title":"Hypoxemia in the absence of blood loss or significant hypotension causes inflammatory cytokine release","volume":"269","author":"Ertel","year":"1995","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1096\/fj.05-4104fje","article-title":"Impact of HIF-1alpha and HIF-2alpha on proliferation and migration of human pulmonary artery fibroblasts in hypoxia","volume":"20","author":"Eul","year":"2006","journal-title":"The FASEB Journal"},{"issue":"90","key":"10.1016\/j.pharmthera.2022.108186_bb0250","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1152\/jappl.2001.90.6.2502","article-title":"Selected Contribution: Pulmonary hypertension in mice following intermittent hypoxia","volume":"1985","author":"Fagan","year":"2001","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0255","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1161\/ATVBAHA.117.309249","article-title":"Mechanical activation of hypoxia-inducible factor 1alpha drives endothelial dysfunction at atheroprone sites","volume":"37","author":"Feng","year":"2017","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0260","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2353\/ajpath.2010.090832","article-title":"Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells","volume":"176","author":"Fijalkowska","year":"2010","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5966\/sctm.2013-0134","article-title":"Targeting the hypoxia-sensing pathway in clinical hematology","volume":"3","author":"Forristal","year":"2014","journal-title":"Stem Cells Translational Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0270","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0275","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1164\/rccm.200911-1663OC","article-title":"Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases","volume":"183","author":"ten Freyhaus","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0280","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jclinpath-2012-200828","article-title":"The role of hypoxia-inducible factor 1 in atherosclerosis","volume":"65","author":"Gao","year":"2012","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0285","doi-asserted-by":"crossref","first-page":"15492","DOI":"10.1038\/ncomms15492","article-title":"Hif-1alpha regulates macrophage-endothelial interactions during blood vessel development in zebrafish","volume":"8","author":"Gerri","year":"2017","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cardiores.2006.07.025","article-title":"Hypoxia- and non-hypoxia-related pulmonary hypertension - established and new therapies","volume":"72","author":"Ghofrani","year":"2006","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0295","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI200524408","article-title":"Oxygen, oxidative stress, hypoxia, and heart failure","volume":"115","author":"Giordano","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0300","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ajpath.2015.03.019","article-title":"Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension","volume":"185","author":"Good","year":"2015","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0305","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2215\/CJN.01760506","article-title":"Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients","volume":"2","author":"Gross","year":"2007","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0310","first-page":"205","article-title":"Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha","volume":"7","author":"Gu","year":"1998","journal-title":"Gene Expression"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0315","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mvr.2016.04.002","article-title":"Heme changes HIF-alpha, eNOS and nitrite production in HUVECs after simvastatin, HU, and ascorbic acid therapies","volume":"106","author":"da Guarda","year":"2016","journal-title":"Microvascular Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0320","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cmet.2005.05.001","article-title":"Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing","volume":"1","author":"Guzy","year":"2005","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0325","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1038\/s41467-018-07495-1","article-title":"Macrophage-derived netrin-1 promotes abdominal aortic aneurysm formation by activating MMP3 in vascular smooth muscle cells","volume":"9","author":"Hadi","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0330","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1126\/science.1088805","article-title":"Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha","volume":"302","author":"Hagen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0335","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pneurobio.2016.06.006","article-title":"Mitochondrial function in hypoxic ischemic injury and influence of aging","volume":"157","author":"Ham","year":"2017","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0340","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1096\/fj.02-0963fje","article-title":"Hypoxia rapidly activates HIF-3alpha mRNA expression","volume":"17","author":"Heidbreder","year":"2003","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0345","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jvs.2005.08.042","article-title":"Increased endogenous angiogenic response and hypoxia-inducible factor-1alpha in human critical limb ischemia","volume":"43","author":"Ho","year":"2006","journal-title":"Journal of Vascular Surgery"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0350","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1126\/science.1852076","article-title":"Cloning of a factor required for activity of the Ah (dioxin) receptor","volume":"252","author":"Hoffman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0355","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/cvr\/cvs014","article-title":"Unfavourable consequences of chronic cardiac HIF-1alpha stabilization","volume":"94","author":"Holscher","year":"2012","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0360","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/stem.1540","article-title":"HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia","volume":"32","author":"HoWangYin","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.pharmthera.2022.108186_bib1038","doi-asserted-by":"crossref","first-page":"1900378","DOI":"10.1183\/13993003.00378-2019","article-title":"Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension","volume":"54","author":"Hu","year":"2019","journal-title":"The European Respiratory Jouranl"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0365","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0370","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway","volume":"95","author":"Huang","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108186_bib1037","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/HYPERTENSIONAHA.111.00160","article-title":"Hypoxia-inducible factor-1alpha in vascular smooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-gamma-angiotensin II receptor type 1 axis","volume":"62","author":"Huang","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0375","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1161\/ATVBAHA.111.230904","article-title":"Bone Gla protein increases HIF-1alpha-dependent glucose metabolism and induces cartilage and vascular calcification","volume":"31","author":"Idelevich","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0380","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/ATVBAHA.116.307784","article-title":"Hypoxia-inducible factor-1alpha in smooth muscle cells protects against aortic aneurysms-brief report","volume":"36","author":"Imanishi","year":"2016","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0385","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2017.09.003","article-title":"Hypoxia inducible factor as a therapeutic target for atherosclerosis","volume":"183","author":"Jain","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0390","doi-asserted-by":"crossref","first-page":"17771","DOI":"10.1074\/jbc.271.30.17771","article-title":"Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1","volume":"271","author":"Jiang","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0395","doi-asserted-by":"crossref","first-page":"C1172","DOI":"10.1152\/ajpcell.1996.271.4.C1172","article-title":"Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension","volume":"271","author":"Jiang","year":"1996","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0400","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1161\/ATVBAHA.116.307900","article-title":"Deletion of LR11 attenuates hypoxia-induced pulmonary arterial smooth muscle cell proliferation with medial thickening in mice","volume":"36","author":"Jiang","year":"2016","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bib1035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.RES.86.3.319","article-title":"Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes","volume":"86","author":"Jung","year":"2000","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0405","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.190332597","article-title":"Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex","volume":"97","author":"Kamura","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0410","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1128\/MCB.01055-15","article-title":"The endothelial prolyl-4-hydroxylase domain 2\/hypoxia-inducible factor 2 axis regulates pulmonary artery pressure in mice","volume":"36","author":"Kapitsinou","year":"2016","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0415","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ydbio.2016.12.013","article-title":"Inactivation of maternal Hif-1alpha at mid-pregnancy causes placental defects and deficits in oxygen delivery to the fetal organs under hypoxic stress","volume":"422","author":"Kenchegowda","year":"2017","journal-title":"Developmental Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0420","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jacc.2005.08.045","article-title":"Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse","volume":"46","author":"Kido","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0425","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/CIRCULATIONAHA.117.033113","article-title":"Selenoprotein P promotes the development of pulmonary arterial hypertension","volume":"138","author":"Kikuchi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0430","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.ymthe.2019.06.011","article-title":"The role of MicroRNA-21 in venous neointimal hyperplasia: implications for targeting miR-21 for VNH treatment","volume":"27","author":"Kilari","year":"2019","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0435","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0440","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCRESAHA.112.300646","article-title":"Hypoxia-inducible factor-1alpha in pulmonary artery smooth muscle cells lowers vascular tone by decreasing myosin light chain phosphorylation","volume":"112","author":"Kim","year":"2013","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0445","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.cdd.4402307","article-title":"Mitochondrial complex III regulates hypoxic activation of HIF","volume":"15","author":"Klimova","year":"2008","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0450","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137557","article-title":"HIF in the heart: development, metabolism, ischemia, and atherosclerosis","volume":"131","author":"Knutson","year":"2021","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108186_bib1031","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41467-018-03105-2","article-title":"Hypoxia-inducible factor 2-alpha-dependent induction of amphiregulin dampens myocardial ischemia-reperfusion injury","volume":"9","author":"Koeppen","year":"2018","journal-title":"Nature Communication"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0455","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14025","article-title":"Hypoxia-inducible factor-1 alpha deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension","volume":"7","author":"Kojima","year":"2019","journal-title":"Physiological Reports"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0460","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvr071","article-title":"Glucose metabolism and cardiac hypertrophy","volume":"90","author":"Kolwicz","year":"2011","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0465","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/01.RES.0000338613.89841.c1","article-title":"Essential role of developmentally activated hypoxia-inducible factor 1alpha for cardiac morphogenesis and function","volume":"103","author":"Krishnan","year":"2008","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0470","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCRESAHA.119.315229","article-title":"Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension","volume":"125","author":"Kurosawa","year":"2019","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0475","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/ATVBAHA.117.308199","article-title":"Tracking adventitial fibroblast contribution to disease: a review of current methods to identify resident fibroblasts","volume":"37","author":"Kuwabara","year":"2017","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bib1039","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/hy1201.097200","article-title":"Hypoxia-inducible factor-1alpha\/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta","volume":"39","author":"Kuwahara","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0480","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/CIRCRESAHA.111.257568","article-title":"PAR-2 inhibition reverses experimental pulmonary hypertension","volume":"110","author":"Kwapiszewska","year":"2012","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0485","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cvr\/cvv243","article-title":"HIF-2alpha-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction","volume":"109","author":"Labrousse-Arias","year":"2016","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0490","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1101\/gad.991402","article-title":"FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor","volume":"16","author":"Lando","year":"2002","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"Hypoxia signaling in human diseases and therapeutic targets","volume":"51","author":"Lee","year":"2019","journal-title":"Experimental & Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bib1036","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/ALN.0000000000003037","article-title":"Transcription-independent Induction of ERBB1 through Hypoxia-inducible Factor 2A Provides Cardioprotection during Ischemia and Reperfusion.","volume":"132","author":"Lee","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0505","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJM200003023420904","article-title":"Early expression of angiogenesis factors in acute myocardial ischemia and infarction","volume":"342","author":"Lee","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0510","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1128\/MCB.01580-07","article-title":"Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein","volume":"28","author":"Lei","year":"2008","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0515","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.3892\/mmr.2016.5752","article-title":"Expression and analyses of the HIF-1 pathway in the lungs of humans with pulmonary arterial hypertension","volume":"14","author":"Lei","year":"2016","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0520","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tcm.2014.10.021","article-title":"Vascular calcification: Mechanisms of vascular smooth muscle cell calcification","volume":"25","author":"Leopold","year":"2015","journal-title":"Trends in Cardiovascular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0525","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.117.032184","article-title":"H19 induces abdominal aortic aneurysm development and progression","volume":"138","author":"Li","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0530","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210008","article-title":"PMN-derived netrin-1 attenuates cardiac ischemia-reperfusion injury via myeloid ADORA2B signaling","volume":"218","author":"Li","year":"2021","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0535","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/690007","article-title":"Pulmonary arterial hypertension in the USA: an epidemiological study in a large insured pediatric population","volume":"7","author":"Li","year":"2017","journal-title":"Pulmonary Circulation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0540","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.4049\/jimmunol.1100479","article-title":"Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension","volume":"187","author":"Li","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108186_bib1041","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/CIRCRESAHA.107.169201","article-title":"Salt-sensitive hypertension induced by decoy of transcription factor hypoxia-inducible factor-1alpha in the renal medulla","volume":"102","author":"Li","year":"2008","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109607","article-title":"Macrophage HIF-2alpha suppresses NLRP3 inflammasome activation and alleviates insulin resistance","volume":"36","author":"Li","year":"2021","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0550","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood-2005-07-3033","article-title":"Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development","volume":"107","author":"Licht","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0555","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jvs.2013.02.240","article-title":"Hypoxia-inducible factor pathway and diseases of the vascular wall","volume":"58","author":"Lim","year":"2013","journal-title":"Journal of Vascular Surgery"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0560","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1172\/JCI84426","article-title":"Hypoxia-inducible factors: key regulators of myeloid cells during inflammation","volume":"126","author":"Lin","year":"2016","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0565","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000548","article-title":"Activation of hypoxia-inducible factor-2 in adipocytes results in pathological cardiac hypertrophy","volume":"2","author":"Lin","year":"2013","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0570","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1158\/1078-0432.CCR-13-0304","article-title":"Molecular pathways: fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer","volume":"19","author":"Linehan","year":"2013","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0575","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/ATVBAHA.115.306861","article-title":"Smooth muscle hypoxia-inducible factor 1alpha links intravascular pressure and atherosclerosis--brief report","volume":"36","author":"Liu","year":"2016","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0580","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ebiom.2018.06.003","article-title":"IL-33 initiates vascular remodelling in hypoxic pulmonary hypertension by up-regulating HIF-1alpha and VEGF expression in vascular endothelial cells","volume":"33","author":"Liu","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0585","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3389\/fphys.2020.00774","article-title":"Novel therapeutic targets for hypoxia-related cardiovascular diseases: the role of HIF-1","volume":"11","author":"Liu","year":"2020","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0590","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/ATVBAHA.118.311714","article-title":"Aqp-1 gene knockout attenuates hypoxic pulmonary hypertension of mice","volume":"39","author":"Liu","year":"2019","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0600","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/HYPERTENSIONAHA.114.04600","article-title":"miR-29a-3p attenuates hypoxic pulmonary hypertension by inhibiting pulmonary adventitial fibroblast activation","volume":"65","author":"Luo","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0605","doi-asserted-by":"crossref","first-page":"14073","DOI":"10.1074\/jbc.M700732200","article-title":"Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells","volume":"282","author":"Makino","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0610","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MOL.0b013e32836484a4","article-title":"Hypoxia in atherosclerosis and inflammation","volume":"24","author":"Marsch","year":"2013","journal-title":"Current Opinion in Lipidology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0615","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/bj20031155","article-title":"Regulation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria-dependent and -independent pathways","volume":"376","author":"Mateo","year":"2003","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0620","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1158\/0008-5472.CAN-10-3320","article-title":"HIF induces human embryonic stem cell markers in cancer cells","volume":"71","author":"Mathieu","year":"2011","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0625","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1172\/JCI98931","article-title":"HIF2alpha in the uterine stroma permits embryo invasion and luminal epithelium detachment","volume":"128","author":"Matsumoto","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0630","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0635","doi-asserted-by":"crossref","first-page":"11032","DOI":"10.1074\/jbc.M208681200","article-title":"Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex","volume":"278","author":"Maynard","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0640","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1084\/jem.182.6.1683","article-title":"A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter","volume":"182","author":"Melillo","year":"1995","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0645","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature14508","article-title":"HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease","volume":"522","author":"Mirtschink","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0650","first-page":"146","article-title":"Gene-environment interaction impacts on heart development and embryo survival","author":"Moreau","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0655","article-title":"Peripheral artery disease","volume":"360","author":"Morley","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0660","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1182\/blood-2007-11-126763","article-title":"HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak","volume":"111","author":"Morote-Garcia","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0665","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage Polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0670","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.RES.0000197816.63513.27","article-title":"Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury","volume":"98","author":"Natarajan","year":"2006","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0675","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.201806-1170OC","article-title":"Evidence for the fucoidan\/P-selectin axis as a therapeutic target in hypoxia-induced pulmonary hypertension","volume":"199","author":"Novoyatleva","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0680","doi-asserted-by":"crossref","first-page":"H542","DOI":"10.1152\/ajpheart.00089.2005","article-title":"HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation","volume":"289","author":"Ockaili","year":"2005","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0685","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0690","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/bies.201300084","article-title":"The Warburg effect then and now: from cancer to inflammatory diseases","volume":"35","author":"Palsson-McDermott","year":"2013","journal-title":"Bioessays"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0695","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/CIRCRESAHA.111.246363","article-title":"Hypoxia is present in murine atherosclerotic plaques and has multiple adverse effects on macrophage lipid metabolism","volume":"109","author":"Parathath","year":"2011","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0700","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1183\/09031936.00092306","article-title":"An epidemiological study of pulmonary arterial hypertension","volume":"30","author":"Peacock","year":"2007","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0705","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1096\/fj.15-273953","article-title":"STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation","volume":"30","author":"Pedroza","year":"2016","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0710","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejheart.2005.10.009","article-title":"Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats","volume":"8","author":"Philipp","year":"2006","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0715","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.15252\/embr.201642198","article-title":"Capture-C reveals preformed chromatin interactions between HIF-binding sites and distant promoters","volume":"17","author":"Platt","year":"2016","journal-title":"EMBO Reports"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0720","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41419-019-1757-0","article-title":"Hypoxia inducible factor 1alpha in vascular smooth muscle cells promotes angiotensin II-induced vascular remodeling via activation of CCL7-mediated macrophage recruitment","volume":"10","author":"Qi","year":"2019","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0725","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1172\/JCI60658","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"122","author":"Rabinovitch","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0730","first-page":"H818","article-title":"Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features","volume":"236","author":"Rabinovitch","year":"1979","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0735","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-physiol-021115-105202","article-title":"Role of intestinal HIF-2alpha in health and disease","volume":"78","author":"Ramakrishnan","year":"2016","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bib1032","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCRESAHA.108.193102","article-title":"Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes","volume":"104","author":"Rane","year":"2009","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0740","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.1683","article-title":"Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia","volume":"10","author":"Rosenberger","year":"2009","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0745","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201512-2380OC","article-title":"Role for runt-related transcription factor 2 in proliferative and calcified vascular lesions in pulmonary arterial hypertension","volume":"194","author":"Ruffenach","year":"2016","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0750","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1074\/jbc.RA117.000440","article-title":"JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension","volume":"293","author":"Sala","year":"2018","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0755","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05602","article-title":"p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload","volume":"446","author":"Sano","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0760","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19124081","article-title":"Identification of novel therapeutic targets for pulmonary arterial hypertension","volume":"19","author":"Satoh","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0765","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1182\/blood-2010-10-314427","article-title":"High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq","volume":"117","author":"Schodel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0770","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1242\/dev.131912","article-title":"Hypoxia promotes production of neural crest cells in the embryonic head","volume":"143","author":"Scully","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0775","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2010.08.006","article-title":"Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning","volume":"1813","author":"Semenza","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0780","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0785","doi-asserted-by":"crossref","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","article-title":"Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1","volume":"271","author":"Semenza","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0790","first-page":"5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0795","first-page":"168","article-title":"Apoptotic cell death under hypoxia","volume":"29","author":"Sendoel","year":"2014","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0800","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10456-018-9600-2","article-title":"miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target","volume":"21","author":"Serocki","year":"2018","journal-title":"Angiogenesis"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0805","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.celrep.2018.03.043","article-title":"Cell autonomous and non-cell autonomous regulation of SMC progenitors in pulmonary hypertension","volume":"23","author":"Sheikh","year":"2018","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0810","doi-asserted-by":"crossref","first-page":"L941","DOI":"10.1152\/ajplung.00528.2005","article-title":"HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes","volume":"291","author":"Shimoda","year":"2006","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0815","doi-asserted-by":"crossref","first-page":"L202","DOI":"10.1152\/ajplung.2001.281.1.L202","article-title":"Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia","volume":"281","author":"Shimoda","year":"2001","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0820","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/jcp.21558","article-title":"The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1","volume":"217","author":"Simon","year":"2008","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0825","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13578-017-0190-2","article-title":"Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer","volume":"7","author":"Singh","year":"2017","journal-title":"Cell & Bioscience"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0830","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/blood-2008-12-193581","article-title":"Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis","volume":"114","author":"Skuli","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0835","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jacc.2007.12.025","article-title":"Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis","volume":"51","author":"Sluimer","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0840","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846401","article-title":"Inherent DNA-binding specificities of the HIF-1alpha and HIF-2alpha transcription factors in chromatin","volume":"20","author":"Smythies","year":"2019","journal-title":"EMBO Reports"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0845","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1152\/jappl.1983.55.5.1445","article-title":"Changes in arteriole in acute and chronic hypoxic pulmonary hypertension and recovery in rat","volume":"55","author":"Sobin","year":"1983","journal-title":"Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0850","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbadis.2018.09.024","article-title":"Hypoxia-inducible factor 1 signalling, metabolism and its therapeutic potential in cardiovascular disease","volume":"1865","author":"Sousa Fialho","year":"2019","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0855","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiological Reviews"},{"issue":"119","key":"10.1016\/j.pharmthera.2022.108186_bb0860","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1152\/japplphysiol.00283.2015","article-title":"Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension","volume":"1985","author":"Stenmark","year":"2015","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0865","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/CS20160865","article-title":"Deletion of hypoxia-inducible factor-1alpha in myeloid lineage exaggerates angiotensin II-induced formation of abdominal aortic aneurysm","volume":"131","author":"Takahara","year":"2017","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0870","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gad.1881410","article-title":"Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis","volume":"24","author":"Takeda","year":"2010","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0875","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/ATVBAHA.115.305551","article-title":"HIF-1alpha and PFKFB3 mediate a tight relationship between proinflammatory activation and anerobic metabolism in atherosclerotic macrophages","volume":"35","author":"Tawakol","year":"2015","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0880","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmed.2016.11.005","article-title":"Targeting vascular remodeling to treat pulmonary arterial hypertension","volume":"23","author":"Thompson","year":"2017","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0885","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1007\/s00018-019-03387-9","article-title":"A long hypoxia-inducible factor 3 isoform 2 is a transcription activator that regulates erythropoietin","volume":"77","author":"Tolonen","year":"2020","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0890","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012673","article-title":"Glucose metabolism in cardiac hypertrophy and heart failure","volume":"8","author":"Tran","year":"2019","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0895","doi-asserted-by":"crossref","first-page":"28612","DOI":"10.1038\/srep28612","article-title":"Inhibition of hypoxia inducible factor-1alpha attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases","volume":"6","author":"Tsai","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0900","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1172\/JCI117858","article-title":"Increased gene expression for VEGF and the VEGF receptors KDR\/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide","volume":"95","author":"Tuder","year":"1995","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0905","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/gyno.1998.5163","article-title":"Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma","volume":"71","author":"Varia","year":"1998","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0910","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1074\/jbc.270.3.1230","article-title":"Purification and characterization of hypoxia-inducible factor 1","volume":"270","author":"Wang","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0915","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/01.RES.0000227551.68124.98","article-title":"Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cells","volume":"98","author":"Wang","year":"2006","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0920","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mam.2016.01.002","article-title":"O2 sensing, mitochondria and ROS signaling: the fog is lifting","volume":"47-48","author":"Waypa","year":"2016","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0925","doi-asserted-by":"crossref","first-page":"C385","DOI":"10.1152\/ajpcell.00485.2010","article-title":"Hypoxia. 2. Hypoxia regulates cellular metabolism","volume":"300","author":"Wheaton","year":"2011","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0930","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1096\/fj.02-0445fje","article-title":"Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs","volume":"17","author":"Wiesener","year":"2003","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0935","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1161\/CIRCRESAHA.112.264473","article-title":"Role of RhoB in the regulation of pulmonary endothelial and smooth muscle cell responses to hypoxia","volume":"110","author":"Wojciak-Stothard","year":"2012","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0940","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25217","article-title":"HIF-1alpha is required for disturbed flow-induced metabolic reprogramming in human and porcine vascular endothelium","volume":"6","author":"Wu","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0945","doi-asserted-by":"crossref","first-page":"H821","DOI":"10.1152\/ajpheart.00140.2013","article-title":"HIF-1alpha in heart: protective mechanisms","volume":"305","author":"Wu","year":"2013","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"1988\u20132003","key":"10.1016\/j.pharmthera.2022.108186_bb0950","article-title":"Intestinal hypoxia-inducible factor 2alpha regulates lactate levels to shape the gut microbiome and alter thermogenesis","volume":"33","author":"Wu","year":"2021","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0955","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.1158\/0008-5472.CAN-07-0783","article-title":"Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor","volume":"67","author":"Xia","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0960","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1159\/000479401","article-title":"PDGF promotes the warburg effect in pulmonary arterial smooth muscle cells via activation of the PI3K\/AKT\/mTOR\/HIF-1alpha signaling pathway","volume":"42","author":"Xiao","year":"2017","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0965","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/j.2040-4603.2011.tb00309.x","article-title":"Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension","volume":"1","author":"Xu","year":"2011","journal-title":"Comprehensive Physiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0970","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1096\/fj.201601357R","article-title":"Antifibrotic effects of cyclosporine A on TGF-beta1-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1alpha","volume":"31","author":"Yamazaki","year":"2017","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0975","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2016.07.010","article-title":"Silencing of hypoxia inducible factor-1alpha gene attenuated angiotensin -induced abdominal aortic aneurysm in apolipoprotein E-deficient mice","volume":"252","author":"Yang","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0980","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3892\/mmr.2015.3689","article-title":"Progress on hypoxia-inducible factor-3: Its structure, gene regulation and biological function (Review)","volume":"12","author":"Yang","year":"2015","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0985","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1172\/JCI5912","article-title":"Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha","volume":"103","author":"Yu","year":"1999","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108186_bib1033","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/HYPERTENSIONAHA.115.06412","article-title":"Rnd3\/RhoE Modulates Hypoxia-Inducible Factor 1alpha\/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1alpha and Regulates Responsive Cardiac Angiogenesis","volume":"67","author":"Yue","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0990","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1074\/jbc.M800102200","article-title":"Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia","volume":"283","author":"Zhang","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108186_bb0995","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIRCRESAHA.118.313058","article-title":"Role of resident stem cells in vessel formation and arteriosclerosis","volume":"122","author":"Zhang","year":"2018","journal-title":"Circulation Research"},{"issue":"937\u2013951","key":"10.1016\/j.pharmthera.2022.108186_bb1000","article-title":"Adipocyte hypoxia-inducible factor 2alpha suppresses atherosclerosis by promoting adipose ceramide catabolism","volume":"30","author":"Zhang","year":"2019","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2022.108186_bb1005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00395-009-0044-0","article-title":"Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1alpha","volume":"105","author":"Zhao","year":"2010","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb1010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.112.103176","article-title":"Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid","volume":"126","author":"Zhao","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2022.108186_bb1015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature14620","article-title":"The zinc transporter ZIP12 regulates the pulmonary vascular response to chronic hypoxia","volume":"524","author":"Zhao","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108186_bb1020","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/bph.15696","article-title":"Combination treatment by HIF-2alpha antagonist and P53 agonist reverses established pulmonary hypertension","volume":"179","author":"Zheng","year":"2022","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108186_bb1025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/stem.2321","article-title":"Human stem cells overexpressing miR-21 promote angiogenesis in critical limb ischemia by targeting CHIP to enhance HIF-1alpha activity","volume":"34","author":"Zhou","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.pharmthera.2022.108186_bb1030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12868-015-0235-6","article-title":"Limb remote ischemic postconditioning protects cerebral ischemia from injury associated with expression of HIF-1alpha in rats","volume":"16","author":"Zong","year":"2015","journal-title":"BMC Neuroscience"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822000808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822000808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:24:37Z","timestamp":1759011877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725822000808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":215,"alternative-id":["S0163725822000808"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108186","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of hypoxia-inducible factors in cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108186"}}